Agomelatine: innovative pharmacological approach in depression.

CNS drugs

Volumn 23 Suppl 2, Issue , 2009, Pages 27-34

  Popoli, Maurizio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; AGOMELATINE; ANTIDEPRESSANT AGENT; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; SEROTONIN 2C RECEPTOR;

ANIMAL; CIRCADIAN RHYTHM; DISEASE MODEL; DRUG ANTAGONISM; DRUG POTENTIATION; HUMAN; MAJOR DEPRESSION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SLEEP DISORDER;

ACETAMIDES; ANIMALS; ANTIDEPRESSIVE AGENTS; CIRCADIAN RHYTHM; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; HUMANS; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2; RECEPTOR, SEROTONIN, 5-HT2C; SLEEP DISORDERS;

EID: 70350717700     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/11318640-000000000-00000     Document Type: Review

References (42)